mannitol has been researched along with Experimental Neoplasms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (85.19) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordfunke, RA; Drijfhout, JW; Fransen, MF; Hennink, WE; Melief, CJ; Ossendorp, F; Sluijter, M; van Steenbergen, MJ | 1 |
| Arens, R; Fransen, MF; Melief, CJ; Morreau, H; Sluijter, M | 1 |
| Cui, ZG; Feril, LB; Fukuda, S; Hasegawa, T; Hatashita, M; Ishimoto, T; Izumi, H; Kagiya, G; Kume, K; Morii, A; Ogawa, R; Watanabe, A | 1 |
| KELLNER, B; NEMETH, L; SELLEI, C | 1 |
| HOLCZINGER, L; KELLNER, B | 1 |
| BALO, J; BESZNYAK, I; JUHASZ, J; KENDREY, G | 2 |
| BIHARI, E; LAPIS, K; NEMETH, L | 1 |
| WHITE, FR | 1 |
| BALO, J; GYENES, G; JUHASZ, J; KENDREY, G; SELLYEI, M | 1 |
| HORVATH, T; VARGHA, L | 1 |
| DUKAT, EG; KJELLBERG, RN; MARK, VH; SOLOWAY, AH | 1 |
| CSANYI, E; HORVATH, P; INSTITORIS, L | 1 |
| GRANTHAM, FH; GULLINO, PM; SMITH, SH | 1 |
| Choi, J; Credit, K; Flessner, MF; He, Z | 1 |
| Barnett, PA; Bigner, DD; Frenkel, EP; Neuwelt, EA | 1 |
| Abdo, KM; Boorman, G; Farnell, DR; Haseman, JK; Kovatch, R; Prejean, JD | 1 |
| Neuringer, LJ; Okunieff, P; Sedlacek, R; Vaupel, P | 1 |
| Ivankovic, S; Kempf, SR | 1 |
| Okunieff, PG; Vaupel, PW | 1 |
| Csányi, E; Halász, M | 1 |
| Benedeczky, I; Jeney, A; Kopper, L; Lapis, K; Szende, B | 1 |
| Baló, J; Vargha, L | 1 |
| Eckhardt, S; Horváth, IP; Institóris, L; Sellei, C | 1 |
| Gál, F; Hercsei, I; Institóris, L; Kellner, B; Németh, L; Somfai, S; Zaka, S | 1 |
| Csányi, E; Horváth, IP; Institóris, L | 1 |
| Elson, LA; Jarman, M; Ross, WC | 1 |
27 other study(ies) available for mannitol and Experimental Neoplasms
| Article | Year |
|---|---|
Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer.
Topics: Animals; Antibodies, Monoclonal; CD40 Antigens; CD8-Positive T-Lymphocytes; Delayed-Action Preparations; Dextrans; Hybridomas; Immunotherapy; Male; Mannitol; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oleic Acids | 2014 |
Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody.
Topics: Animals; Antibodies, Monoclonal; CD40 Antigens; CD8-Positive T-Lymphocytes; Cell Line, Transformed; Cell Line, Tumor; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flow Cytometry; Male; Mannitol; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oleic Acids; T-Lymphocytes, Cytotoxic; Time Factors; Treatment Outcome | 2011 |
Regulation of gene expression in retrovirus vectors by X-ray and proton beam radiation with artificially constructed promoters.
Topics: Animals; Dimethyl Sulfoxide; Gene Expression Regulation, Viral; Genes, Transgenic, Suicide; Genetic Vectors; HeLa Cells; Humans; Mannitol; Mice; Neoplasms, Experimental; Oxidative Stress; Promoter Regions, Genetic; Protons; Retroviridae; TATA Box; Transcriptional Activation; X-Rays | 2012 |
Pathological and clinical effects of 1.6-bis(beta-chloraethylamino)-1.6-desoxy-D-mannite-dichlorhydrate/BCM.
Topics: Animals; Mannitol; Mechlorethamine; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1957 |
[Effect of fractionated doses of BCM [1,6-bix (beta-chloroethylamino)-1,6-desoxy-D-mannitol dihydrochloride] on guérin carcinoma of the rat].
Topics: Animals; Carcinoma; Dose Fractionation, Radiation; Mannitol; Mechlorethamine; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats | 1957 |
Effect of 1, 6-di-(2-bromoethylamino)-1, 6-dideoxy-D-mannitol dihydrobromide on tumours of laboratory animals.
Topics: Animals; Animals, Laboratory; Mannitol; Mechlorethamine; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1959 |
[Effects of radiotherapy and chemotherapy on metastases of Guerin rat carcinoma].
Topics: Animals; Mannitol; Mechlorethamine; Neoplasms, Experimental; Neoplasms, Second Primary; Nitrogen Mustard Compounds; X-Rays | 1959 |
Tumour-inhibiting action of 1,6-di-(2-bromoethyl-amino)-1,6-dideoxy-D-mannitol dihydrobromide [(DBM (R13)].
Topics: Animals; Humans; Mannitol; Mechlorethamine; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1959 |
Mannitol myleran.
Topics: Busulfan; Mannitol; Neoplasms; Neoplasms, Experimental | 1962 |
EXPERIMENTAL INVESTIGATIONS INTO THE ANTITUMORAL ACTIVITY OF 1,2,5,6-TETRAHYDROMETHANE-SULPHONYL-D-MANNITOL (TSM).
Topics: Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Ehrlich Tumor; Mannitol; Mice; Neoplasms, Experimental; Pharmacology; Rats; Research; Sarcoma 37; Sarcoma, Experimental; Sarcoma, Yoshida | 1964 |
NEW METHANESULPHONYL SUGAR ALCOHOLS AND THEIR CYTOSTATIC ACTIVITY.
Topics: Alcohols; Animals; Antineoplastic Agents; Cytostatic Agents; Mannitol; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma; Sarcoma, Yoshida; Sugar Alcohols | 1964 |
CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Ependymoma; Mannitol; Melphalan; Mice; Neoplasms; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive; Pharmacology; Research; Toxicology | 1964 |
[ON THE EFFECT OF GLUCOSE ON THE TOXIC AND THERAPEUTIC EFFECTS OF 1,6-DIBROMO-1,6-D-DIDESOXYMANNITOL IN ANIMAL EXPERIMENTS].
Topics: Aminopterin; Animal Experimentation; Animals; Antineoplastic Agents; Busulfan; Carcinoma, Ehrlich Tumor; Dactinomycin; Glucose; Mannitol; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 37; Sarcoma, Yoshida; Toxicology | 1964 |
THE INTERSTITIAL WATER SPACE OF TUMORS.
Topics: Animals; Body Fluids; Carbon Isotopes; Carcinoma; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Chlorine; Extracellular Space; Fibrosarcoma; Liver Neoplasms; Mannitol; Neoplasms, Experimental; Physiology; Radioisotopes; Rats; Research; Sodium Isotopes; Water | 1965 |
Physiological characterization of human ovarian cancer cells in a rat model of intraperitoneal antineoplastic therapy.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Injections, Intraperitoneal; Mannitol; Metabolic Clearance Rate; Neoplasms, Experimental; Ovarian Neoplasms; Rats; Rats, Nude; Tissue Distribution; Trastuzumab | 2004 |
Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
Topics: Alpharetrovirus; Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Dexamethasone; Glioma; Mannitol; Methotrexate; Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1982 |
Absence of carcinogenic response in F344 rats and B6C3F1 mice given D-mannitol in the diet for two years.
Topics: Animals; Body Weight; Eating; Female; Male; Mannitol; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Rats; Rats, Inbred F344; Time Factors | 1983 |
Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry.
Topics: Animals; Energy Metabolism; Female; Fibrosarcoma; Glucose; Injections, Intraperitoneal; Lasers; Magnetic Resonance Spectroscopy; Male; Mannitol; Mice; Mice, Inbred C3H; Microcirculation; Neoplasm Transplantation; Neoplasms, Experimental | 1989 |
Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats.
Topics: Animals; Cisplatin; Female; Fibrosarcoma; Kidney Neoplasms; Leukemia, Experimental; Male; Mannitol; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Role of hypovolemic hemoconcentration in dose-dependent flow decline observed in murine tumors after intraperitoneal administration of glucose or mannitol.
Topics: Animals; Blood Glucose; Blood Volume; Fibrosarcoma; Glucose; Hematocrit; Hyperglycemia; Lasers; Mannitol; Mice; Mice, Inbred C3H; Microcirculation; Neoplasms, Experimental | 1988 |
1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
Topics: Animals; Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Cells; DNA; DNA, Neoplasm; Dogs; Drug Evaluation, Preclinical; Ethers, Cyclic; Lethal Dose 50; Mannitol; Mesylates; Mice; Mitosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Rats; RNA; RNA, Neoplasm; Sugar Alcohols | 1973 |
Cell population kinetics, biochemical, ultrastructural changes occurring during growth of experimental tumors and their relevance to cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Division; DNA, Neoplasm; Lymphoma; Mannitol; Methods; Microscopy, Electron; Neoplasms, Experimental | 1973 |
Chemistry and bioassay of Zitostop.
Topics: Animals; Antineoplastic Agents; Biological Assay; Chemical Phenomena; Chemistry; Mannitol; Mice; Neoplasms, Experimental; Rats; Sulfones | 1971 |
Comparative data on the action mechanism of 1,6-dibromo-1,6-dideoxy-D-mannitol and 1,4-dimethanesulfonyloxy-n-butane.
Topics: Animals; Antineoplastic Agents; Busulfan; Leukemia, Myeloid; Mannitol; Neoplasms, Experimental; Rabbits | 1966 |
Investigation into the correlation of cytostatic activity with the in vitro diepoxide formation on some terminally substituted hexitols.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Chromatography, Thin Layer; Ethers, Cyclic; Hexoses; Hydrocarbons; Hydrocarbons, Halogenated; Injections, Intraperitoneal; Leukemia, Experimental; Lymphoma; Mannitol; Mice; Neoplasms, Experimental; Rats | 1970 |
Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
Topics: Animals; Antineoplastic Agents; Bromine; Carcinoma; Carcinoma, Ehrlich Tumor; Mannitol; Mice; Neoplasms, Experimental; Rats; Sarcoma 180; Sarcoma 37; Sarcoma, Yoshida | 1967 |
Toxicity, haematological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol.
Topics: Anemia; Animals; Antineoplastic Agents; Anuria; Blood Platelet Disorders; Blood Platelets; Busulfan; Ethers, Cyclic; Glucose; Leukemia, Experimental; Leukocytes; Mannitol; Mice; Neoplasms, Experimental; Rats | 1968 |